{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:44:49Z","timestamp":1758815089150,"version":"3.41.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.pharep.2013.11.009","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T09:07:17Z","timestamp":1397380037000},"page":"430-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Reboxetine and its influence on the action of classical antiepileptic drugs in the mouse maximal electroshock model"],"prefix":"10.1007","volume":"66","author":[{"given":"Kinga K.","family":"Borowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rados\u0142aw","family":"Zarczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"Latalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kornel M.","family":"Borowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2013.11.009_bib0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bcp.2012.08.016","article-title":"Rhythm and blues: animal models of epilepsy and depression comorbidity","volume":"85","author":"Epps","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharep.2013.11.009_bib0060","first-page":"183","article-title":"Studies of drug effects on electrically induced extensor seizures and clinical implications","volume":"172","author":"Chen","year":"1968","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pharep.2013.11.009_bib0120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yebeh.2011.07.016","article-title":"One-year seizure prognosis in epilepsy patients treated with antidepressants","volume":"22","author":"Okazaki","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.pharep.2013.11.009_bib0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1527-3458.2008.00040.x","article-title":"Therapeutic potential of fluoxetine in neurological disorders","volume":"14","author":"Mostert","year":"2008","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.pharep.2013.11.009_bib0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1054\/jocn.2000.0896","article-title":"Epilepsy, depression and antidepressant drugs","volume":"8","author":"Salzberg","year":"2001","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.pharep.2013.11.009_bib0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1615\/CritRevNeurobiol.v13.i4.10","article-title":"A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders","volume":"13","author":"Jobe","year":"1999","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.pharep.2013.11.009_bib0010","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1471-4159.2006.04277.x","article-title":"Serotonin and epilepsy","volume":"100","author":"Bagdy","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharep.2013.11.009_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(97)01215-6","article-title":"Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT 1A receptors","volume":"336","author":"Browning","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2013.11.009_bib0085","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neubiorev.2004.06.008","article-title":"The role of norepinephrine in epilepsy: from the bench to the bedside","volume":"28","author":"Giorgi","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharep.2013.11.009_bib0100","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.yebeh.2005.07.014","article-title":"The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant","volume":"7","author":"Jobe","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.pharep.2013.11.009_bib0130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0006-8993(96)00291-0","article-title":"The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin","volume":"724","author":"Pasini","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2013.11.009_bib0170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0163-7258(02)00218-8","article-title":"The role of catecholamines in seizure susceptibility: new results using genetically engineered mice","volume":"94","author":"Weinshenker","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharep.2013.11.009_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2007.03.015","article-title":"Chronically administered fluoxetine enhances the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model","volume":"567","author":"Borowicz","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2013.11.009_bib0030","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00213-009-1698-x","article-title":"Effect of acute and chronic treatment with milnacipran potentiates the anticonvulsant activity of conventional antiepileptic drugs in the maximal electroshock-induced seizures in mice","volume":"207","author":"Borowicz","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharep.2013.11.009_bib0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2011.08.042","article-title":"Effect of acutely and chronically administered venlafaxine on the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock model","volume":"670","author":"Borowicz","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2013.11.009_bib0050","first-page":"83","article-title":"Fluoxetine enhances the anticonvulsant effects of conventional antiepileptic drugs in maximal electroshock seizures in mice","volume":"58","author":"Borowicz","year":"2006","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2013.11.009_bib0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00213-007-0878-9","article-title":"Acute and chronic treatment with mianserin differentially affects the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model","volume":"195","author":"Borowicz","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharep.2013.11.009_bib0180","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0006-3223(99)00291-7","article-title":"Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor","volume":"47","author":"Wong","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharep.2013.11.009_bib0155","first-page":"e255","article-title":"Reboxetine in clinical practice: a review","volume":"163","author":"Sepede","year":"2012","journal-title":"Clin Ter"},{"key":"10.1016\/j.pharep.2013.11.009_bib0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.euroneuro.2007.07.005","article-title":"A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder","volume":"18","author":"Papakostas","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2013.11.009_bib0080","doi-asserted-by":"crossref","first-page":"c4737","DOI":"10.1136\/bmj.c4737","article-title":"Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials","volume":"341","author":"Eyding","year":"2010","journal-title":"Brit Med J"},{"key":"10.1016\/j.pharep.2013.11.009_bib0090","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1212\/01.wnl.0000302369.24230.c6","article-title":"Animal model studies application to human patients","volume":"69","author":"Holmes","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pharep.2013.11.009_bib0110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2013.11.009_bib0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000134913","article-title":"Une nouvelle methode simple pour explorer l\u2019action tranquilisante: le test de la cheminee","volume":"3","author":"Boissier","year":"1960","journal-title":"Med Exp (Basel)"},{"key":"10.1016\/j.pharep.2013.11.009_bib0165","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/321864a0","article-title":"Benzodiazepines impair and beta-carbolines enhance performance in learning and memory tasks","volume":"321","author":"Venault","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.pharep.2013.11.009_bib0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0924-977X(02)00009-3","article-title":"2-Chloroadenosine, a preferential agonist of adenosine A1 receptors, enhances the anticonvulsant activity of carbamazepine and clonazepam in mice","volume":"12","author":"Borowicz","year":"2002","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2013.11.009_bib0095","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.yebeh.2003.08.020","article-title":"Common pathogenic mechanisms between depression and epilepsy: an experimental perspective","volume":"4","author":"Jobe","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.pharep.2013.11.009_bib0040","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1734-1140(12)70910-6","article-title":"Trazodone reduces the anticonvulsant action of certain classical antiepileptics in the mouse maximal electroshock model","volume":"64","author":"Borowicz","year":"2012","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2013.11.009_bib0140","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1365-2826.2011.02234.x","article-title":"Up-regulation of neurosteroid biosynthesis as a pharmacological strategy to improve behavioural deficits in a putative mouse model of post-traumatic stress disorder","volume":"24","author":"Pinna","year":"2012","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.pharep.2013.11.009_bib0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0278-5846(94)90033-7","article-title":"Effects of chronic mianserin administration on serotonin metabolism and receptors in the 5-hydroxytryptophan depression model","volume":"18","author":"Akiyoshi","year":"1994","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharep.2013.11.009_bib0185","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0278-5846(90)90004-Z","article-title":"Depression and antidepressant therapy: receptor dynamics","volume":"14","author":"Zemlan","year":"1990","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharep.2013.11.009_bib0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/026988110201600205","article-title":"Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex","volume":"16","author":"Dawson","year":"2002","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharep.2013.11.009_bib0135","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF02245579","article-title":"Up-regulation of beta 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments","volume":"115","author":"P\u00e4lvim\u00e4ki","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharep.2013.11.009_bib0175","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.lfs.2007.04.039","article-title":"Effect of long-term administration of the antidepressant drug milnacipran on serotonergic and noradrenergic neurotransmission in the rat hippocampus","volume":"81","author":"Weiss","year":"2007","journal-title":"Life Sci"},{"key":"10.1016\/j.pharep.2013.11.009_bib0145","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1017\/S1461145705005754","article-title":"Chronic administration of venlafaxine fails to attenuate 5-HT1A receptor function at the level of receptor-G protein interaction","volume":"9","author":"Rossi","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2013.11.009_bib0160","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0893-133X(01)00284-6","article-title":"Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus","volume":"25","author":"Szabo","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharep.2013.11.009_bib0065","first-page":"E147","article-title":"The efficacy of reboxetine as an antidepressant, a meta-analysis of both continuous (mean HAM-D score) and dichotomous (response rate) outcomes","volume":"54","author":"Chuluunkhuu","year":"2008","journal-title":"Kobe J Med Sci"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S173411401400139X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S173411401400139X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:35:19Z","timestamp":1752611719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2013.11.009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S173411401400139X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2013.11.009","relation":{},"ISSN":["1734-1140"],"issn-type":[{"type":"print","value":"1734-1140"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reboxetine and its influence on the action of classical antiepileptic drugs in the mouse maximal electroshock model","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2013.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}